青光眼进展。临床实践指南。
Glaucoma progression. Clinical practice guide.
作者信息
Jaumandreu L, Antón A, Pazos M, Rodriguez-Uña I, Rodriguez Agirretxe I, Martinez de la Casa J M, Ayala M E, Parrilla-Vallejo M, Dyrda A, Díez-Álvarez L, Rebolleda G, Muñoz-Negrete F J
机构信息
Servicio de Oftalmología, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain; Red de Oftalmología RETICS OFTARED del Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Institut Català de la Retina (ICR), Barcelona, Spain; Universitat Internacional de Catalunya (UIC), Barcelona, Spain; Red de Oftalmología RETICS OFTARED del Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
出版信息
Arch Soc Esp Oftalmol (Engl Ed). 2023 Jan;98(1):40-57. doi: 10.1016/j.oftale.2022.08.003. Epub 2022 Sep 8.
OBJECTIVE
To provide general recommendations that serve as a guide for the evaluation and management of glaucomatous progression in daily clinical practice based on the existing quality of clinical evidence.
METHODS
After defining the objectives and scope of the guide, the working group was formed and structured clinical questions were formulated following the PICO (Patient, Intervention, Comparison, Outcomes) format. Once all the existing clinical evidence had been independently evaluated with the AMSTAR 2 (Assessment of Multiple Systematic Reviews) and Cochrane "Risk of bias" tools by at least two reviewers, recommendations were formulated following the Scottish Intercollegiate Guideline network (SIGN) methodology.
RESULTS
Recommendations with their corresponding levels of evidence that may be useful in the interpretation and decision-making related to the different methods for the detection of glaucomatous progression are presented.
CONCLUSIONS
Despite the fact that for many of the questions the level of scientific evidence available is not very high, this clinical practice guideline offers an updated review of the different existing aspects related to the evaluation and management of glaucomatous progression.
目的
基于现有临床证据质量，提供一般性建议，作为日常临床实践中青光眼病情进展评估与管理的指导。
方法
在确定指南的目标和范围后，成立了工作组，并按照PICO（患者、干预措施、对照、结局）格式制定结构化临床问题。至少两名评审员使用AMSTAR 2（多种系统评价评估）和Cochrane“偏倚风险”工具对所有现有临床证据进行独立评估后，按照苏格兰校际指南网络（SIGN）方法制定建议。
结果
提出了具有相应证据水平的建议，这些建议可能有助于对检测青光眼病情进展的不同方法进行解读和决策。
结论
尽管许多问题的现有科学证据水平不高，但本临床实践指南对与青光眼病情进展评估和管理相关的不同现有方面进行了最新综述。
Zotero 插件